Viewing Study NCT02404051


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2025-12-25 @ 9:34 PM
Study NCT ID: NCT02404051
Status: UNKNOWN
Last Update Posted: 2016-06-15
First Post: 2015-01-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer
Sponsor: Consorzio Oncotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module